Boehringer Ingelheim is seeking a Spring Co-Op in the Immune Regulation group within the Oncology Research department at Ridgefield CT. You will contribute to in vitro cancer immunology work, developing immune suppression assays and translational platforms for evaluating novel therapeutics.
The role offers exposure to cross-functional teams and a collaborative environment. Qualified candidates are graduate students in immunology/oncology with hands-on in vitro assay experience (FACS/ELISA) and a
#J-18808-Ljbffr
The following opening is for a Spring Co-Op: Immune Regulation in Oncology with BioCT Innovation Commons.
The advertised compensation is 33.000 - 45.000.
We aim to respond to suitable candidates as soon as possible.
Full responsibilities and requirements are described in the listing above.
Learn more about the Spring Co-Op: Immune Regulation in Oncology role in the description above.
We appreciate your interest in this position.